TLI Logo

Home Profiles Scott G. Filler, MD

Investigator, Infectious Diseases and Immunology
Distinguished Professor of Medicine, David Geffen School of Medicine at UCLA
Executive Career Training Officer, The Lundquist Institute

Scott G. Filler, MD

Areas of Expertise

Research

Dr. Filler’s research, funded continuously by the NIH for more than 30 years, focuses on the pathogenesis of infections caused by Candida spp. and Aspergillus fumigatus. His laboratory investigates the mechanisms by which these fungi invade and damage host cells, how the innate immune system senses and responds to fungal infection, and the signal transduction pathways that govern these processes in both the host and the pathogen. Dr. Filler has mentored 11 postdoctoral fellows, 5 of whom have gone on to faculty positions (one supported by a K99/R00 award), as well as 4 PhD students and 4 visiting scientists. As a member of the K12 committee of the UCLA Clinical and Translational Science Institute (CTSI), he is strongly committed to helping junior faculty advance to independently funded principal investigators.

Biography

Scott G. Filler, M.D., is Distinguished Professor of Medicine at the David Geffen School of Medicine at UCLA, Academic Chief of Research in the Division of Infectious Diseases at Harbor-UCLA Medical Center, and an Investigator at the Lundquist Institute for Biomedical Innovation. A graduate of Dartmouth College and the UCLA School of Medicine, he completed his internal medicine and infectious diseases training at Harbor-UCLA, where he subsequently served as Chief of the Division of Infectious Diseases from 2014 to 2022. His NIH-funded research, now in its fourth decade, investigates the pathogenesis of invasive infections caused by Candida species and Aspergillus fumigatus, with a focus on the mechanisms by which these fungi invade and damage host cells and the signal transduction pathways that govern the host response; this work has produced more than 225 peer-reviewed publications and multiple patents, including the basis for a Candida vaccine that has advanced to Phase II clinical trials. Dr. Filler is a Fellow of the American Academy of Microbiology and the Infectious Diseases Society of America, a member of the Association of American Physicians, an Editor of mBio and Associate Editor of PLoS Pathogens, and has chaired multiple NIH study sections and the ASM Conference on Candida and Candidiasis.

Publications

Google Scholar